Freedom Capital Markets Maintains Buy on Inspire Medical Systems, Raises Price Target to $97
Benzinga Newsdesk 1 month ago
Analyst RatingsNewsPrice Target
Freedom Capital Markets analyst Keith Hinton maintains Inspire Medical Systems (NYSE:INSP) with a Buy and raises the price target from $71 to $97.
Freedom Capital Markets analyst Keith Hinton maintains Inspire Medical Systems (NYSE:INSP) with a Buy and raises the price target from $71 to $97.